SCHEMBL2821094

SCHEMBL2821094

CCCCc1cnc(-c2cccnc2)s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 4/20 0.49
CYP2C19 P33261 4/20 0.49
CYP2C9 P11712 4/20 0.49
CYP3A4 P08684 3/20 0.49
CYP19A1 P11511 1/20 0.49
PPARA Q07869 1/20 0.46
HPGDS O60760 1/20 0.46
CYP2A6 P11509 6/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
NPC1 O15118 2/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
S1PR1 P21453 2/20 0.42
KDM4E B2RXH2 2/20 0.42
ATP4A P20648 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11396105 0.91 HPGDS (0.48) CYP2D6CYP2C19CYP2C9CYP3A4CYP19A1
SCHEMBL27369174 0.87 HPGDS (0.47) CYP2D6CYP2C19CYP2C9CYP3A4CYP19A1
SCHEMBL152405 0.84 HPGDS (0.50) CYP2D6CYP2C19CYP2C9CYP3A4CYP19A1
SCHEMBL2821115 0.84 HDAC1 (0.56) HPGDSHDAC1HDAC2SMN1; SMN2NPC1
SCHEMBL8655761 0.84 HPGDS (0.45) CYP2D6CYP2C19CYP2C9CYP3A4CYP19A1
SCHEMBL8093091 0.84 HRH1 (0.49) CYP2D6CYP2C19CYP2C9CYP3A4HPGDS
SCHEMBL23146081 0.78 CYP2A6 (0.61) CYP2D6CYP2C19CYP2C9CYP3A4CYP19A1
SCHEMBL8655571 0.76 CYP2C9 (0.46) CYP2D6CYP2C19CYP2C9CYP3A4CYP19A1
SCHEMBL2227620 0.76 CYP3A4 (0.46) CYP2D6CYP2C19CYP2C9CYP3A4CYP19A1
SCHEMBL12844399 0.74 CYP11B1 (0.54) HPGDSHDAC1HDAC2SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240890-A1 Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same DONG WHA PHARMACEUTICAL IND. CO., LTD. 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240890-A1 Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same CMA1, IL5, HRH4 CYP2D6 546/4885CYP2C19 143/4885CYP2C9 233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.